Literature DB >> 11390658

RAG transposase can capture and commit to target DNA before or after donor cleavage.

M B Neiditch1, G S Lee, M A Landree, D B Roth.   

Abstract

The discovery that the V(D)J recombinase functions as a transposase in vitro suggests that transposition by this system might be a potent source of genomic instability. To gain insight into the mechanisms that regulate transposition, we investigated a phenomenon termed target commitment that reflects a functional association between the RAG transposase and the target DNA. We found that the V(D)J recombinase is quite promiscuous, forming productive complexes with target DNA both before and after donor cleavage, and our data indicate that the rate-limiting step for transposition occurs after target capture. Formation of stable target capture complexes depends upon the presence of active-site metal binding residues (the DDE motif), suggesting that active-site amino acids in RAG-1 are critical for target capture. The ability of the RAG transposase to commit to target prior to cleavage may result in a preference for transposition into nearby targets, such as immunoglobulin and T-cell receptor loci. This could bias transposition toward relatively "safe" regions of the genome. A preference for localized transposition may also have influenced the evolution of the antigen receptor loci.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390658      PMCID: PMC87090          DOI: 10.1128/MCB.21.13.4302-4310.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination.

Authors:  M A Landree; J A Wibbenmeyer; D B Roth
Journal:  Genes Dev       Date:  1999-12-01       Impact factor: 11.361

2.  Factors responsible for target site selection in Tn10 transposition: a role for the DDE motif in target DNA capture.

Authors:  M S Junop; D B Haniford
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

Review 3.  Target site selection in transposition.

Authors:  N L Craig
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

4.  RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination.

Authors:  A Agrawal; D G Schatz
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

5.  Initiation of V(D)J recombination in a cell-free system.

Authors:  D C van Gent; J F McBlane; D A Ramsden; M J Sadofsky; J E Hesse; M Gellert
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

Review 6.  The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses.

Authors:  S M Lewis
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

7.  Characterization of the transposition pattern of the Ac element in Arabidopsis thaliana using endonuclease I-SceI.

Authors:  C Machida; H Onouchi; J Koizumi; S Hamada; E Semiarti; S Torikai; Y Machida
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

8.  Functional analysis of coordinated cleavage in V(D)J recombination.

Authors:  D R Kim; M A Oettinger
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

9.  Preferential transposition of Drosophila P elements to nearby chromosomal sites.

Authors:  J Tower; G H Karpen; N Craig; A C Spradling
Journal:  Genetics       Date:  1993-02       Impact factor: 4.562

Review 10.  The old and the restless.

Authors:  S M Lewis; G E Wu
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  13 in total

1.  Targeted transposition by the V(D)J recombinase.

Authors:  Gregory S Lee; Matthew B Neiditch; Richard R Sinden; David B Roth
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Regulation of RAG1/RAG2-mediated transposition by GTP and the C-terminal region of RAG2.

Authors:  Chia-Lun Tsai; David G Schatz
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

3.  The C-terminal portion of RAG2 protects against transposition in vitro.

Authors:  Sheryl K Elkin; Adam G Matthews; Marjorie A Oettinger
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

4.  Inverse transposition by the RAG1 and RAG2 proteins: role reversal of donor and target DNA.

Authors:  I-hung Shih; Meni Melek; Nadeesha D Jayaratne; Martin Gellert
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

5.  A RAG-1/RAG-2 tetramer supports 12/23-regulated synapsis, cleavage, and transposition of V(D)J recombination signals.

Authors:  Patrick C Swanson
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

6.  Evidence of a critical architectural function for the RAG proteins in end processing, protection, and joining in V(D)J recombination.

Authors:  Chia-Lun Tsai; Anna H Drejer; David G Schatz
Journal:  Genes Dev       Date:  2002-08-01       Impact factor: 11.361

7.  In vitro processing of the 3'-overhanging DNA in the postcleavage complex involved in V(D)J joining.

Authors:  Tadashi Nishihara; Fumikiyo Nagawa; Hirofumi Nishizumi; Masami Kodama; Satoshi Hirose; Reiko Hayashi; Hitoshi Sakano
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Ordered DNA release and target capture in RAG transposition.

Authors:  Adam G W Matthews; Sheryl K Elkin; Marjorie A Oettinger
Journal:  EMBO J       Date:  2004-02-26       Impact factor: 11.598

9.  Identification and characterization of a gain-of-function RAG-1 mutant.

Authors:  Aleksei N Kriatchko; Dirk K Anderson; Patrick C Swanson
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

10.  Biochemical characterization of a SET and transposase fusion protein, Metnase: its DNA binding and DNA cleavage activity.

Authors:  Yaritzabel Roman; Masahiko Oshige; Young-Ju Lee; Kristie Goodwin; Millie M Georgiadis; Robert A Hromas; Suk-Hee Lee
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.